Patent · US Active

Intracellular kinase inhibitors

US8604031B2 · kind B2 · utility

2Cited by
153References
62Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 18, 2007
Grant dateDec 10, 2013
Priority date—
Expiry dateAug 21, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D401/06
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Intracellular kinase inhibitors and their therapeutic uses for patients with T cell malignancies, B cell malignancies, autoimmune disorders, and transplanted organs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.